4//SEC Filing
Klassen Preston 4
Accession 0000950170-25-011851
CIK 0001505512other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:00 PM ET
Size
5.3 KB
Accession
0000950170-25-011851
Insider Transaction Report
Form 4
Klassen Preston
DirectorPresident & Head of R & D
Transactions
- Award
Stock Option (Right to Buy)
2025-01-30+675,000→ 675,000 totalExercise: $1.00Exp: 2035-01-29→ Common Stock (675,000 underlying)
Footnotes (1)
- [F1]The stock option commenced vesting on January 1, 2025 and will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001493056
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 5:00 PM ET
- Size
- 5.3 KB